{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T08:05:13Z","timestamp":1792051513385,"version":"4.4.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2008,8,1]],"date-time":"2008-08-01T00:00:00Z","timestamp":1217548800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2008,8]]},"DOI":"10.1016\/j.vaccine.2008.06.013","type":"journal-article","created":{"date-parts":[[2008,9,10]],"date-time":"2008-09-10T13:41:45Z","timestamp":1221054105000},"page":"L37-L48","source":"Crossref","is-referenced-by-count":164,"special_numbering":"S11","title":["Cervical Cancer Screening Programs in Latin America and the Caribbean"],"prefix":"10.1016","volume":"26","author":[{"given":"Raul","family":"Murillo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maribel","family":"Almonte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ferrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar A.","family":"Gamboa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9","family":"Jer\u00f3nimo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Lazcano-Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.06.013_bib1","unstructured":"Ferlay J, Bray F, Pisani P, Parkin DM. GLOBOCAN 2002: Cancer Incidence, Mortality and Prevalence Worldwide. IARC CancerBase No. 5. Version 2.0. Lyon: IARC Press, 2004."},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.013_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bpobgyn.2005.10.007","article-title":"Worldwide burden of gynaecological cancer: the size of the problem","volume":"20","author":"Sankaranarayanan","year":"2006","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"issue":"20","key":"10.1016\/j.vaccine.2008.06.013_bib3","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1056\/NEJMp058171","article-title":"The promise of global cervical-cancer prevention","volume":"353","author":"Schiffman","year":"2005","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.013_bib4","first-page":"290","article-title":"Trends in cervical cancer mortality in the Americas","volume":"30","author":"Robles","year":"1996","journal-title":"Bull Pan Am Health Organ"},{"issue":"Suppl 11","key":"10.1016\/j.vaccine.2008.06.013_bib5","doi-asserted-by":"crossref","first-page":"L1","DOI":"10.1016\/j.vaccine.2008.05.043","article-title":"Burden and trends of type-specific human papillomavirus infections and related diseases in the Latin America and Caribbean region","volume":"26","author":"Parkin","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2008.06.013_bib6","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1016\/j.vaccine.2006.05.121","article-title":"Chapter 8: Screening for cervical cancer in developing countries","volume":"24","author":"Denny","year":"2006","journal-title":"Vaccine"},{"issue":"10","key":"10.1016\/j.vaccine.2008.06.013_bib7","first-page":"954","article-title":"Effective screening programmes for cervical cancer in low- and middle-income developing countries","volume":"79","author":"Sankaranarayanan","year":"2001","journal-title":"Bull World Health Organ"},{"key":"10.1016\/j.vaccine.2008.06.013_bib8","series-title":"A Situational Analysis of Cervical Cancer in Latin America and the Caribbean","author":"Lewis","year":"2004"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2008.06.013_bib9","doi-asserted-by":"crossref","first-page":"S449","DOI":"10.1590\/S0036-36342003000900020","article-title":"Recommendations for cervical cancer screening programs in developing countries. The need for equity and technological development","volume":"45","author":"Lazcano-Ponce","year":"2003","journal-title":"Salud Publica Mex"},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.013_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1002\/ijc.10453","article-title":"Determinants of cervical cancer rates in developing countries","volume":"100","author":"Drain","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2008.06.013_bib11","unstructured":"Program for the control of cervical cancer in Peru. Bull Pan Am Health Organ 1996; 30(4):413."},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.013_bib12","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/sonc.2001.21966","article-title":"Cervical cancer in Latin America","volume":"28","author":"Eluf-Neto","year":"2001","journal-title":"Semin Oncol"},{"key":"10.1016\/j.vaccine.2008.06.013_bib13","unstructured":"IARC Working Group on the Evaluation of Cancer Preventive Strategies. Cervix Cancer Screening. IARC Handbooks of Cancer Prevention Vol. 10. Lyon: IARC Press, 2005."},{"key":"10.1016\/j.vaccine.2008.06.013_bib14","unstructured":"Comisi\u00f3n Nacional de C\u00e1ncer Cervicouterino. Diagn\u00f3stico y tratamiento c\u00e1ncer cervicouterino. Protocolo AUGE. Ministerio de Salud, Gobierno de Chile, 2004."},{"issue":"2","key":"10.1016\/j.vaccine.2008.06.013_bib15","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/fampra\/19.2.189","article-title":"Prevention of cervical cancer in a poor population in Brazil","volume":"19","author":"Mauad","year":"2002","journal-title":"Fam Pract"},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.013_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1001\/jama.261.5.737","article-title":"The Papanicolaou test for cervical cancer detection. A triumph and a tragedy","volume":"261","author":"Koss","year":"1989","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.013_bib17","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1023\/A:1008875818033","article-title":"Evaluation model of the Mexican national program for early cervical cancer detection and proposals for a new approach","volume":"9","author":"Lazcano-Ponce","year":"1998","journal-title":"Cancer Causes Control"},{"issue":"12","key":"10.1016\/j.vaccine.2008.06.013_bib18","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0959-8049(03)00315-0","article-title":"Assessing the evidence for organised cancer screening programmes","volume":"39","author":"Madlensky","year":"2003","journal-title":"Eur J Cancer"},{"issue":"3","key":"10.1016\/j.vaccine.2008.06.013_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1002\/ijc.10692","article-title":"A proposal for cervical screening information systems in developing countries","volume":"102","author":"Marrett","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.vaccine.2008.06.013_bib20","unstructured":"Lazcano-Ponce E, Palacio-Mej\u00eda L, Allen-Leigh B, Yunes E, Alonso P, Schiavon R, et al. Decreasing cervical cancer mortality in Mexico: the effect of birth rates, Papanicolaou-smear coverage, and validity of cytology diagnostic. Cancer Epidemiol Biomarkers Prev, in press."},{"issue":"5","key":"10.1016\/j.vaccine.2008.06.013_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1590\/S0036-36342002000500007","article-title":"Implementation and evaluation of a national external quality control program for cervical cytology in Mexico","volume":"44","author":"Flisser","year":"2002","journal-title":"Salud Publica Mex"},{"issue":"1","key":"10.1016\/j.vaccine.2008.06.013_bib22","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000326279","article-title":"External quality assurance for cervical cytology in developing countries. Experience in Peru and Nicaragua","volume":"48","author":"Salvetto","year":"2004","journal-title":"Acta Cytol"},{"issue":"8544","key":"10.1016\/j.vaccine.2008.06.013_bib23","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/S0140-6736(87)92695-X","article-title":"Trends in mortality from cervical cancer in the Nordic countries: association with organised screening programmes","volume":"1","author":"Laara","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2008.06.013_bib24","series-title":"Incidencia y Mortalidad del Cancer en Costa Rica 1990\u20132003","author":"Ortiz","year":"2005"},{"key":"10.1016\/j.vaccine.2008.06.013_bib25","unstructured":"World Health Organization (WHO). WHO Mortality Database: Tables. Available at: http:\/\/www.who.int\/healthinfo\/morttables\/en\/index.html (last accessed: April 2008)."},{"key":"10.1016\/j.vaccine.2008.06.013_bib26","unstructured":"Health Canada. Cervical Cancer Screening in Canada: 1998 Surveillance Report. Cat. No.H39-616\/1998E. Minister of Public Works and Government Services Canada, 2002."},{"key":"10.1016\/j.vaccine.2008.06.013_bib27","unstructured":"Parkin DM, Whelan SL, Ferlay J, Storm H. Cancer Incidence in Five Continents, Volumes I to VIII. IARC CancerBase No. 7. Lyon: IARC Press, 2005."},{"key":"10.1016\/j.vaccine.2008.06.013_bib28","series-title":"Incidencia estimada y mortalidad por c\u00e1ncer en Colombia, 1995\u20131999","author":"Pi\u00f1eros","year":"2005"},{"issue":"6","key":"10.1016\/j.vaccine.2008.06.013_bib29","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1093\/ije\/21.6.1050","article-title":"Screening for cervical cancer in Latin America: a case-control study","volume":"21","author":"Herrero","year":"1992","journal-title":"Int J Epidemiol"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.013_bib30","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1590\/S0036-36342008000400005","article-title":"Cost-effectiveness of conventional cytology and HPV-DNA testing for cervical-cancer screening in Colombia","volume":"50","author":"Gamboa","year":"2008","journal-title":"Salud Publica Mex"},{"issue":"19","key":"10.1016\/j.vaccine.2008.06.013_bib31","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1093\/jnci\/94.19.1469","article-title":"Costs and benefits of different strategies to screen for cervical cancer in less-developed countries","volume":"94","author":"Mandelblatt","year":"2002","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"10.1016\/j.vaccine.2008.06.013_bib32","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1056\/NEJMsa044278","article-title":"Cost-effectiveness of cervical-cancer screening in five developing countries","volume":"353","author":"Goldie","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2008.06.013_bib33","unstructured":"Pan American Health Organization (PAHO). Health Analysis and Information Systems Area. Regional Core Health Data Initiative; Technical Health Information System. Washington DC: PAHO, 2005."},{"key":"10.1016\/j.vaccine.2008.06.013_bib34","unstructured":"World Health Organization (WHO). WHO vaccine-preventable diseases: monitoring system, 2006 global summary. Geneva: WHO, Department of Immunization, Vaccines and Biologicals, 2006."},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2008.06.013_bib35","doi-asserted-by":"crossref","first-page":"S90","DOI":"10.1016\/j.vaccine.2006.05.122","article-title":"Chapter 10: New dimensions in cervical cancer screening","volume":"24","author":"Cuzick","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 10","key":"10.1016\/j.vaccine.2008.06.013_bib36","doi-asserted-by":"crossref","first-page":"K29","DOI":"10.1016\/j.vaccine.2008.06.019","article-title":"Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries","volume":"26","author":"Cuzick","year":"2008","journal-title":"Vaccine"},{"issue":"Suppl 11","key":"10.1016\/j.vaccine.2008.06.013_bib37","doi-asserted-by":"crossref","first-page":"L49","DOI":"10.1016\/j.vaccine.2008.05.025","article-title":"New Approaches to Cervical Cancer Screening in Latin America and the Caribbean","volume":"26","author":"Herrero","year":"2008","journal-title":"Vaccine"},{"issue":"4","key":"10.1016\/j.vaccine.2008.06.013_bib38","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ijc.22757","article-title":"Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru","volume":"121","author":"Almonte","year":"2007","journal-title":"Int J Cancer"},{"issue":"9585","key":"10.1016\/j.vaccine.2008.06.013_bib39","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/S0140-6736(07)61195-7","article-title":"Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial","volume":"370","author":"Sankaranarayanan","year":"2007","journal-title":"Lancet"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2008.06.013_bib40","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1016\/j.vaccine.2006.05.061","article-title":"Chapter 20: Issues in planning cervical cancer screening in the era of HPV vaccination","volume":"24","author":"Franco","year":"2006","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2008.06.013_bib41","doi-asserted-by":"crossref","first-page":"S178","DOI":"10.1016\/j.vaccine.2006.05.116","article-title":"Chapter 21: Modelling the impact of HPV vaccines on cervical cancer and screening programmes","volume":"24","author":"Garnett","year":"2006","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2008.06.013_bib42","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1056\/NEJMp078053","article-title":"Introducing HPV vaccine in developing countries\u2013key challenges and issues","volume":"356","author":"Agosti","year":"2007","journal-title":"N Engl J Med"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007317?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08007317?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,25]],"date-time":"2018-12-25T19:28:55Z","timestamp":1545766135000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08007317"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,8]]},"references-count":42,"alternative-id":["S0264410X08007317"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.06.013","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2008,8]]}}}